Wilms tumour
暂无分享,去创建一个
S. Behjati | M. Gessler | K. Pritchard-Jones | M. Maschietto | J. Brok | G. Vujanić | J. Geller | Angela Polanco | F. Spreafico | C. Fernandez | S. Luna-Fineman | K. Nakata | V. Paintsil
[1] K. Pritchard-Jones,et al. The clinical impact of observer variability in lung nodule classification in children with Wilms tumour , 2022, Pediatric blood & cancer.
[2] M. Chintagumpala,et al. Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.
[3] C. Rübe,et al. Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP). , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] C. Rübe,et al. Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature , 2021, Cancers.
[5] Y. Kaneko,et al. Wilms tumour surveillance in at-risk children: Literature review and recommendations from the SIOP-Europe Host Genome Working Group and SIOP Renal Tumour Study Group. , 2021, European journal of cancer.
[6] R. Williams,et al. Comparative analysis of the clinical characteristics and outcomes of patients with Wilms tumor in the United Kingdom and Japan , 2021, Pediatric blood & cancer.
[7] P. Ehrlich,et al. Surgical Management of Wilms Tumor (Nephroblastoma) and Renal Cell Carcinoma in Children and Young Adults. , 2021, Surgical oncology clinics of North America.
[8] S. Behjati,et al. Maturation Block in Childhood Cancer. , 2021, Cancer discovery.
[9] R. Kuiper,et al. TRIM28 variants and Wilms' tumour predisposition , 2021, The Journal of pathology.
[10] S. Behjati,et al. Predisposition to cancer in children and adolescents. , 2021, The Lancet. Child & adolescent health.
[11] S. Knapp,et al. Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers , 2021, Cancer Research.
[12] J. Aitken,et al. Stage at diagnosis and survival by stage for the leading childhood cancers in three populations of sub‐Saharan Africa , 2021, International journal of cancer.
[13] J. Dome,et al. New approaches to risk stratification for Wilms tumor. , 2020, Current opinion in pediatrics.
[14] B. Geoerger,et al. Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting. , 2020, European journal of cancer.
[15] S. Furth,et al. Kidney Outcomes and Hypertension in Survivors of Wilms Tumor: A Prospective Cohort Study. , 2020, The Journal of pediatrics.
[16] A. Apple,et al. Wilms Tumor in Sub-Saharan Africa: Molecular and Social Determinants of a Global Pediatric Health Disparity , 2020, Frontiers in Oncology.
[17] C. Rübe,et al. The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy. , 2020, The Lancet. Child & adolescent health.
[18] K. Ness,et al. Long‐term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study , 2020, Pediatric blood & cancer.
[19] G. Chagaluka,et al. Working Together to Build a Better Future for Children With Cancer in Africa , 2020, JCO global oncology.
[20] S. D. de Souza,et al. Assessment of somatic mutations in urine and plasma of Wilms tumor patients , 2020, Cancer medicine.
[21] E. Steliarova-Foucher,et al. Incidence of childhood renal tumours: An international population‐based study , 2020, International journal of cancer.
[22] M. Chintagumpala,et al. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group , 2020, Cancer.
[23] Ninad Oak,et al. Recent advances in Wilms tumor predisposition. , 2020, Human molecular genetics.
[24] G. Chagaluka,et al. Improvement of overall survival in the Collaborative Wilms Tumour Africa Project , 2020, Pediatric blood & cancer.
[25] E. Papaemmanuil,et al. 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood , 2020, Cancer.
[26] H. Brisse,et al. From Wilms to kidney tumors: which ones require a biopsy? , 2020, Pediatric Radiology.
[27] D. Rodeberg,et al. Minimally invasive surgery for pediatric renal tumors: A systematic review by the APSA Cancer Committee. , 2020, Journal of pediatric surgery.
[28] J. Sandberg,et al. Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2. , 2020, AJR. American journal of roentgenology.
[29] P. Kemmeren,et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity , 2020, Nature Communications.
[30] James R. Anderson,et al. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] G. Vujanić,et al. Renal Tumors of Childhood—A Histopathologic Pattern-Based Diagnostic Approach , 2020, Cancers.
[32] H. Correa,et al. Health disparities among Tennessee pediatric renal tumor patients. , 2020, Journal of pediatric surgery.
[33] Kayla L. Stratton,et al. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. , 2020, The Lancet. Oncology.
[34] H. Brisse,et al. Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group. , 2020, European journal of cancer.
[35] Guía Familiar,et al. Children's Oncology Group , 2020, Definitions.
[36] K. Pritchard-Jones,et al. The role of imaging in the initial investigation of paediatric renal tumours. , 2020, The Lancet. Child & adolescent health.
[37] G. Nason,et al. A systematic review of genitourinary injuries arising from rugby and football. , 2020, Journal of pediatric urology.
[38] C. Rübe,et al. Is radiotherapy required in first‐line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP‐RTSG, AIEOP, JWiTS, and UKCCSG , 2019, Pediatric blood & cancer.
[39] Matthew D. Young,et al. Embryonal precursors of Wilms tumor , 2019, Science.
[40] M. Chintagumpala,et al. Global Disparities in Wilms Tumor. , 2019, The Journal of surgical research.
[41] Heather L. Mulder,et al. Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor , 2019, Nature Communications.
[42] Chuan He,et al. Progress toward liquid biopsies in pediatric solid tumors , 2019, Cancer and Metastasis Reviews.
[43] A. Millar,et al. Surgery for the complex Wilms tumour , 2019, Pediatric Surgery International.
[44] J. Vandesompele,et al. Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study , 2020, Epigenetics.
[45] M. Gessler,et al. High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro , 2019, Oncogene.
[46] F. Locatelli,et al. High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation , 2019, Bone Marrow Transplantation.
[47] James R. Anderson,et al. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] R. Williams,et al. The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial , 2019, Pediatric blood & cancer.
[49] S. Seal,et al. Identification of new Wilms tumour predisposition genes: an exome sequencing study , 2019, The Lancet. Child & adolescent health.
[50] R. Atun,et al. Estimating the total incidence of global childhood cancer: a simulation-based analysis. , 2019, The Lancet. Oncology.
[51] K. Pritchard-Jones,et al. Science and health for all children with cancer , 2019, Science.
[52] A. Toutain,et al. Overgrowth syndromes — clinical and molecular aspects and tumour risk , 2019, Nature Reviews Endocrinology.
[53] T. Margaritis,et al. Tubuloids derived from human adult kidney and urine for personalized disease modeling , 2019, Nature Biotechnology.
[54] B. Dawson,et al. Tegavivint and the β-catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma. , 2019, Journal of the National Cancer Institute.
[55] M. Gessler,et al. TRIM28 haploinsufficiency predisposes to Wilms tumor , 2019, International journal of cancer.
[56] S. Behjati,et al. The genetic changes of Wilms tumour , 2019, Nature Reviews Nephrology.
[57] M. Gessler,et al. Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation , 2018, International journal of cancer.
[58] O. Delattre,et al. Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis , 2018, International journal of cancer.
[59] James R. Anderson,et al. Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study‐5 (NWTS‐5) , 2018, Pediatric blood & cancer.
[60] J. Dome,et al. Outcome of Wilms tumor patients with bone metastasis enrolled on National Wilms Tumor Studies 1‐5: A report from the Children's Oncology Group , 2018, Pediatric blood & cancer.
[61] M. Coleman,et al. Childhood cancer burden: a review of global estimates. , 2019, The Lancet. Oncology.
[62] I. Helenowski,et al. Cardiac-Sparing Whole Lung Intensity Modulated Radiation Therapy in Children With Wilms Tumor: Final Report on Technique and Abdominal Field Matching to Maximize Normal Tissue Protection. , 2019, Practical radiation oncology.
[63] C. Clark,et al. An alternative approach to contrast-enhanced imaging: diffusion-weighted imaging and T1-weighted imaging identifies and quantifies necrosis in Wilms tumour , 2018, European Radiology.
[64] D. Gerhard,et al. A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children’s Oncology Group study , 2018, PloS one.
[65] P. Ehrlich,et al. Technical Considerations for Nephron-Sparing Surgery in Children: What Is Needed to Preserve Renal Units? , 2018, The Journal of surgical research.
[66] G. Rivard,et al. Management of acquired von Willebrand syndrome. , 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[67] James R. Anderson,et al. Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] M. Gessler,et al. The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol , 2018, Nature Reviews Urology.
[69] A. Attarbaschi,et al. Outcome of two patients with bilateral nephroblastomatosis/Wilms tumour treated with an add-on 13-cis retinoic acid therapy – Case report , 2018, Pediatric hematology and oncology.
[70] A. Davidoff,et al. Bilateral Wilms Tumor: A Surgical Perspective , 2018, Children.
[71] S. Fosså,et al. Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE) , 2018, JMIR research protocols.
[72] George D. Cresswell,et al. Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors , 2018, Translational oncology.
[73] Sarah A. Teichmann,et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors , 2018, Science.
[74] C. Bodkyn,et al. Baseline characteristics and outcomes of children with cancer in the English‐speaking Caribbean: A multinational retrospective cohort , 2018, Pediatric blood & cancer.
[75] A. Zauber,et al. Health supervision for people with Bloom syndrome , 2018, American journal of medical genetics. Part A.
[76] K. Pritchard-Jones,et al. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database. , 2018, The Lancet. Oncology.
[77] R. Hammer,et al. Loss of Dis3l2 partially phenocopies Perlman syndrome in mice and results in up-regulation of Igf2 in nephron progenitor cells , 2018, Genes & development.
[78] M. Hudson,et al. Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[79] A. Reeve,et al. Germline mutations and somatic inactivation of TRIM28 in Wilms tumour , 2018, PLoS genetics.
[80] G. Chagaluka,et al. Improved outcome at end of treatment in the collaborative Wilms tumour Africa project , 2018, Pediatric blood & cancer.
[81] H. Clevers,et al. Organoids in cancer research , 2018, Nature Reviews Cancer.
[82] James R. Anderson,et al. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] R. Hennekam,et al. Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement , 2018, Nature Reviews Endocrinology.
[84] James R. Anderson,et al. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[85] C. Rübe,et al. Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol , 2017, Nature Reviews Urology.
[86] S. Luna-Fineman,et al. Effects of malnutrition on treatment‐related morbidity and survival of children with cancer in Nicaragua , 2017, Pediatric blood & cancer.
[87] K. Pritchard-Jones,et al. Paediatrics: Integrating genomics to dig deeper into Wilms tumour biology , 2017, Nature Reviews Urology.
[88] M. Chintagumpala,et al. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group , 2017, Annals of surgery.
[89] Qing-Rong Chen,et al. A Children's Oncology Group and TARGET Initiative Exploring the Genetic Landscape of Wilms Tumor , 2017, Nature Genetics.
[90] M. Gessler,et al. TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia , 2017, The journal of pathology. Clinical research.
[91] K. Pritchard-Jones,et al. Bilateral Wilms tumour: a review of clinical and molecular features , 2017, Expert Reviews in Molecular Medicine.
[92] Michael W. Bishop,et al. Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort , 2017, The Journal of clinical endocrinology and metabolism.
[93] R. Comstock,et al. Epidemiology of Chest, Rib, Thoracic Spine, and Abdomen Injuries Among United States High School Athletes, 2005/06 to 2013/14 , 2017, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[94] K. Pritchard-Jones,et al. Review of phase I and II trials for Wilms' tumour - Can we optimise the search for novel agents? , 2017, European journal of cancer.
[95] P. Nikkels,et al. Apparent diffusion coefficient as it relates to histopathology findings in post-chemotherapy nephroblastoma: a feasibility study , 2017, Pediatric Radiology.
[96] Eva Steliarova-Foucher,et al. International incidence of childhood cancer, 2001–10: a population-based registry study , 2017, The Lancet. Oncology.
[97] S. Seal,et al. Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation , 2017, Nature Genetics.
[98] H. Jalanko,et al. Renal findings in patients with Mulibrey nanism , 2017, Pediatric Nephrology.
[99] N. Sebire,et al. Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience , 2017, Pediatric blood & cancer.
[100] James R. Anderson,et al. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532 , 2017, Annals of surgery.
[101] D. Papagiannopoulos,et al. Revisiting Sports Precautions in Children With Solitary Kidneys and Congenital Anomalies of the Kidney and Urinary Tract. , 2017, Urology.
[102] M. Ortega,et al. An Analysis of Treatment Failure in Wilms Tumor (WT): A Report from the Central American Association of Pediatric Hematology/Oncology (AHOPCA) , 2016 .
[103] Liliana Vásquez,et al. Factors associated with the latency to diagnosis of childhood cancer in Peru , 2016, Pediatric blood & cancer.
[104] A. Naranjo,et al. Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group , 2016, Pediatric blood & cancer.
[105] Kathy Pritchard-Jones,et al. Biology and treatment of renal tumours in childhood. , 2016, European journal of cancer.
[106] Richard A. Moore,et al. Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group , 2016, Clinical Cancer Research.
[107] James R. Anderson,et al. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[108] J. Carey,et al. Wilms tumor and trisomy 18: Is there an association? , 2016, American journal of medical genetics. Part C, Seminars in medical genetics.
[109] M. O'sullivan,et al. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[110] George D. Cresswell,et al. Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications , 2016, EBioMedicine.
[111] M. Gessler,et al. Mutually exclusive BCOR internal tandem duplications and YWHAE‐NUTM2 fusions in clear cell sarcoma of kidney: not the full story , 2016, The Journal of pathology.
[112] W. Foulkes,et al. Evolution of Renal Cysts to Anaplastic Sarcoma of Kidney in a Child With DICER1 Syndrome , 2016, Pediatric blood & cancer.
[113] A. McMahon. Development of the Mammalian Kidney. , 2016, Current topics in developmental biology.
[114] K. Pritchard-Jones,et al. Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial , 2015, The Lancet.
[115] K. Pritchard-Jones,et al. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[116] K. Pritchard-Jones,et al. Paediatrics: Long-term effects of Wilms tumour therapy on renal function , 2015, Nature Reviews Urology.
[117] D. Srivastava,et al. Renal function in survivors of nonsyndromic Wilms tumor treated with unilateral radical nephrectomy , 2015, Cancer.
[118] R. Goldsby,et al. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor , 2015, Pediatric blood & cancer.
[119] M. Fukuzawa,et al. Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney , 2015, Nature Genetics.
[120] K. Pritchard-Jones,et al. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). , 2015, European journal of cancer.
[121] Y. Arai,et al. A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation , 2015, British Journal of Cancer.
[122] Eckart Meese,et al. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. , 2015, Cancer cell.
[123] Richard A. Moore,et al. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. , 2015, Cancer cell.
[124] M. Shrubsole,et al. Risk factors for abandonment of Wilms tumor therapy in Kenya , 2015, Pediatric blood & cancer.
[125] D. Gisselsson,et al. Multiple mechanisms of MYCN dysregulation in Wilms tumour , 2015, Oncotarget.
[126] T. Eden,et al. The Collaborative Wilms Tumour Africa Project; baseline evaluation of Wilms tumour treatment and outcome in eight institutes in sub-Saharan Africa. , 2015, European journal of cancer.
[127] D. Green,et al. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). , 2015, European journal of cancer.
[128] N. Graf,et al. Current Concepts in Surgery for Wilms Tumor—The Risk and Function-Adapted Strategy , 2014, European Journal of Pediatric Surgery.
[129] Jianbo Sun,et al. Eya1 interacts with Six2 and Myc to regulate expansion of the nephron progenitor pool during nephrogenesis. , 2014, Developmental cell.
[130] James R. Anderson,et al. TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia , 2014, PloS one.
[131] Dinesh Rakheja,et al. Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours , 2014, Nature Communications.
[132] P. Radice,et al. The IGF signalling pathway in Wilms tumours - A report from the ENCCA Renal Tumours Biology-driven drug development workshop , 2014, Oncotarget.
[133] S. Seal,et al. Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour , 2014, Nature Communications.
[134] P. Grundy,et al. Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour , 2014, Nature Communications.
[135] J. Dome,et al. Risk stratification for wilms tumor: current approach and future directions. , 2014, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[136] Hao Zhu,et al. Lin28 sustains early renal progenitors and induces Wilms tumor , 2014, Genes & development.
[137] K. Pritchard-Jones,et al. Why should survivors of childhood renal tumor and others with only one kidney be denied the chance to play contact sports? , 2014, Expert review of anticancer therapy.
[138] N. Breslow,et al. Outcome of patients with stage II/favorable histology wilms tumor with and without local tumor spill: A report from the National Wilms Tumor Study Group , 2014, Pediatric blood & cancer.
[139] Silvia Rossi,et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. , 2014, The Lancet. Oncology.
[140] P. Radice,et al. Is Wilms Tumor a Candidate Neoplasia for Treatment with WNT/β-Catenin Pathway Modulators?—A Report from the Renal Tumors Biology-Driven Drug Development Workshop , 2013, Molecular Cancer Therapeutics.
[141] K. Pritchard-Jones,et al. Incidence and outcomes of patients with late recurrence of Wilms' tumor , 2013, Pediatric blood & cancer.
[142] T. Eden,et al. Clinical trials to improve childhood cancer care and survival in sub-Saharan Africa , 2013, Nature Reviews Clinical Oncology.
[143] K. Pritchard-Jones,et al. Treatment of Wilms tumor in low-income countries: challenges and potential solutions. , 2013, Future oncology.
[144] James R. Anderson,et al. Children's Oncology Group's 2013 blueprint for research: Renal tumors , 2013, Pediatric blood & cancer.
[145] A. Naranjo,et al. Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group. , 2013, Radiology.
[146] K. Pritchard-Jones,et al. SIOP PODC: Clinical guidelines for the management of children with Wilms tumour in a low income setting , 2013, Pediatric blood & cancer.
[147] D. Machin,et al. An international strategy to determine the role of high dose therapy in recurrent Wilms' tumour. , 2013, European journal of cancer.
[148] A. Naranjo,et al. Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee. , 2013, Journal of pediatric surgery.
[149] D. Green. The evolution of treatment for Wilms tumor. , 2013, Journal of pediatric surgery.
[150] G. Chagaluka,et al. Management of Children With a Wilms Tumor in Malawi, Sub-Saharan Africa , 2012, Journal of pediatric hematology/oncology.
[151] H. van Tinteren,et al. Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[152] H. Caron,et al. The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour , 2012, Pediatric blood & cancer.
[153] K. Pritchard-Jones,et al. The contribution of chest CT-scan at diagnosis in children with unilateral Wilms' tumour. Results of the SIOP 2001 study. , 2012, European journal of cancer.
[154] M. Molyneux,et al. Practical issues in relation to clinical trials in children in low-income countries: experience from the front line , 2012, Archives of Disease in Childhood.
[155] N. Breslow,et al. Treatments and outcomes for end-stage renal disease following Wilms tumor , 2012, Pediatric Nephrology.
[156] Nazneen Rahman,et al. Stratification of Wilms tumor by genetic and epigenetic analysis , 2012, Oncotarget.
[157] J. Opitz,et al. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility , 2012, Nature Genetics.
[158] Maria Grazia Valsecchi,et al. Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. , 2012, European journal of cancer.
[159] G. Armstrong,et al. Twenty‐five year follow‐up of childhood Wilms tumor: A report from the Childhood Cancer Survivor Study , 2011, Pediatric blood & cancer.
[160] M. Gessler,et al. Retinoic acid pathway activity in wilms tumors and characterization of biological responses in vitro , 2011, Molecular Cancer.
[161] G. Levitt. Renal tumours: long-term outcome , 2011, Pediatric Nephrology.
[162] N. Breslow,et al. Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. , 2011, The Journal of urology.
[163] M. Rivera,et al. The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification. , 2011, Developmental cell.
[164] V. Huff,et al. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene , 2011, Nature Reviews Cancer.
[165] Fei Gao,et al. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. , 2011, The Journal of clinical investigation.
[166] H. Heij,et al. Challenges and outcome of Wilms' tumour management in a resource-constrained setting. , 2010, African journal of paediatric surgery : AJPS.
[167] A. Boddy,et al. Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate. , 2010, European journal of cancer.
[168] James R. Anderson,et al. Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5. , 2010, International journal of radiation oncology, biology, physics.
[169] M. Gessler,et al. Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor , 2010, Clinical Cancer Research.
[170] N. Breslow,et al. Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group. , 2010, International journal of radiation oncology, biology, physics.
[171] L. Strong,et al. Wt 1 ablation and Igf 2 upregulation in mice result in Wilms tumors with elevated ERK 1 / 2 phosphorylation , 2010 .
[172] H. Caron,et al. Acute malnutrition is common in Malawian patients with a Wilms tumour: A role for peanut butter , 2009, Pediatric blood & cancer.
[173] M. Gessler,et al. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact , 2009, Genes, chromosomes & cancer.
[174] J. Dome,et al. Treatment of relapsed Wilms tumors: lessons learned , 2009, Expert review of anticancer therapy.
[175] Gretchen M. Williams,et al. DICER1 Mutations in Familial Pleuropulmonary Blastoma , 2009, Science.
[176] H. Jalanko,et al. High frequency of tumours in Mulibrey nanism , 2009, The Journal of pathology.
[177] N. Breslow,et al. Early and late mortality after diagnosis of wilms tumor. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[178] A. Ashworth,et al. Perilobar Nephrogenic Rests Are Nonobligate Molecular Genetic Precursor Lesions of Insulin-Like Growth Factor-II-Associated Wilms Tumors , 2008, Clinical Cancer Research.
[179] P. Ehrlich,et al. Ureteral extension in Wilms' tumor: a report from the National Wilms' Tumor Study Group (NWTSG). , 2008, Journal of pediatric surgery.
[180] R. Arora,et al. Wilms tumour in Sudan , 2008, Pediatric blood & cancer.
[181] N. Breslow,et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group , 2008, Pediatric blood & cancer.
[182] S. G. Rice. Medical Conditions Affecting Sports Participation , 1994, Pediatrics.
[183] K. Matthay,et al. A phase 2 trial of all‐trans‐retinoic acid in combination with interferon‐α2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study , 2007 .
[184] N. Breslow,et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group , 2007, Pediatric blood & cancer.
[185] C. Mathew,et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer , 2007, Nature Genetics.
[186] A. Reeve,et al. Sequential WT1 and CTNNB1 mutations and alterations of β-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies , 2006, Journal of Clinical Pathology.
[187] P. Babyn,et al. Wilms tumour: prognostic factors, staging, therapy and late effects , 2007, Pediatric Radiology.
[188] N. Rahman,et al. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice , 2006, Archives of Disease in Childhood.
[189] Kevin C Oeffinger,et al. Chronic health conditions in adult survivors of childhood cancer. , 2006, The New England journal of medicine.
[190] Eva Steliarova-Foucher,et al. Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. , 2006, European journal of cancer.
[191] N. Breslow,et al. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor , 2006, Pediatric blood & cancer.
[192] N. Breslow,et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[193] N. Rahman,et al. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour , 2006, Journal of Medical Genetics.
[194] N. Breslow,et al. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. , 2005, The Journal of urology.
[195] N. Breslow,et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[196] Bernard V Fischbach,et al. WAGR Syndrome: A Clinical Review of 54 Cases , 2005, Pediatrics.
[197] E. Perlman. Pediatric Renal Tumors: Practical Updates for the Pathologist , 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[198] R. Hennekam,et al. High incidence of malformation syndromes in a series of 1,073 children with cancer , 2005, American journal of medical genetics. Part A.
[199] S. Seal,et al. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour , 2005, Journal of Medical Genetics.
[200] D. Green,et al. The treatment of stages I-IV favorable histology Wilms' tumor. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[201] N. Breslow,et al. Epigenetic differences between Wilms' tumours in white and east-Asian children , 2004, The Lancet.
[202] N. Breslow,et al. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[203] Dieter Harms,et al. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. , 2002, Medical and pediatric oncology.
[204] K. Yokomori,et al. Cancer-prone syndrome of mosaic variegated aneuploidy and total premature chromatid separation: report of five infants. , 2001, American journal of medical genetics.
[205] N. Breslow,et al. Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[206] J. Varley,et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations , 2001, Oncogene.
[207] N. Breslow,et al. Intravascular Extension of Wilms Tumor , 2001, Annals of surgery.
[208] N. Breslow,et al. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[209] R. Potter,et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[210] N Graf,et al. THE ROLE OF PREOPERATIVE CHEMOTHERAPY IN THE MANAGEMENT OF WILMS' TUMOR: The SIOP Studies , 2000 .
[211] M. von Knebel Doeberitz,et al. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. , 1999, Cancer research.
[212] J. Roganovic,et al. Epidemiology of childhood cancer. , 1999, IARC scientific publications.
[213] P Scambler,et al. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. , 1998, Human molecular genetics.
[214] N E Breslow,et al. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[215] Marc Fellous,et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome , 1997, Nature Genetics.
[216] S. Schneider,et al. Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[217] N. Breslow,et al. Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group. , 1996, The American journal of surgical pathology.
[218] S. Chew,et al. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. , 1995, American journal of human genetics.
[219] E. Franco,et al. A randomized clinical trial of single‐dose versus fractionated‐dose dactinomycin in the treatment of wilms' tumor. Results after extended follow‐up , 1994 .
[220] R. Mueller. The Denys-Drash syndrome. , 1994, Journal of medical genetics.
[221] O. Ishida,et al. Familial primary hyperparathyroidism complicated with Wilms' tumor. , 1994, Internal medicine.
[222] P. Voûte,et al. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[223] D. Housman,et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome , 1991, Cell.
[224] D. Parkin,et al. International variations in the incidence of childhood renal tumours. , 1990, British Journal of Cancer.
[225] P. Voûte,et al. Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[226] A. Poustka,et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping , 1990, Nature.
[227] D. Housman,et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.
[228] N. Kiviat,et al. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. , 1990, Pediatric pathology.
[229] E. Beckwith,et al. Histopathology and prognosis of Wilms tumor Results from the first national wilms' tumor study , 1978, Cancer.
[230] A. Meadows,et al. Patterns of second malignant neoplasms in children , 1977, Cancer.
[231] D. Hays. Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' Tumor—Preliminary results of a controlled clinical trial conduced the internatinal society of pediatric oncology (S.I.O.P.) , 1977 .
[232] P. Voûte,et al. Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin d, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the international society of paediatric oncology (S.I.O.P.) , 1976, Cancer.
[233] H. Bartsch,et al. International Agency for Research on Cancer. , 1969, WHO chronicle.
[234] James R. Anderson,et al. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor : A Report From the Children ' s Oncology Group Study AREN 0532 , 2022 .